Table 4. Toxicities of patients with oligometastases or oligorecurrence to MLNs treated with SRT.
Total, n (%) | ||||
---|---|---|---|---|
Acute toxicities | Any Grade | Grade 3 | Grade 4 | Grade 5 |
Pneumonitis | 6 (7) | 1 (1) | 0 | 0 |
Esophagitis | 3 (4) | 1 (1) | 0 | 0 |
Tracheitis | 3 (4) | 2 (2) | 0 | 0 |
Chest pain | 1 (1) | 0 | 0 | 0 |
Agranulocytosis | 1 (1) | 0 | 0 | 0 |
Thrombocytopenia | 1 (1) | 0 | 0 | 0 |
Late toxicities | ||||
Tachycardia | 1 (1) | 0 | 0 | 0 |
Lung fibrosis | 1 (1) | 0 | 0 | 0 |
Atelectasis | 1 (1) | 0 | 0 | 0 |
Tracheoesophageal fistula | 2 (1) | 0 | 0 | 2 (2) |
Esophageal-mediastinal fistula | 1 (1) | 0 | 0 | 1 (1) |
Abbreviations: MLNs: mediastinal lymph nodes; SRT: stereotacticradiation therapy.